Latest Breaking News On - Phase 3 katherine trial - Page 1 : comparemela.com

Nicholas P. McAndrew, MD, MSCE, discusses how updated clinical trial findings are shifting the treatment paradigm in HER2-positive metastatic breast cancer.

San antonioUnited statesLos angelesNicholasp mcandrewDavid geffen school of medicineUniversity of californiaAntonio breast cancer symposiumScience summitGeffen schoolPhase 3 katherine trialPhase 3 her2climb 02 trial nct03975647